BellRing Brands (BRBR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
16 Dec, 2025Executive summary
Annual meeting scheduled for January 28, 2026, will be held virtually via live audio webcast; record date is December 8, 2025.
Stockholders will vote on the election of five directors, ratification of the auditor, and an advisory say-on-pay vote.
Proxy materials and annual report are available online, with electronic delivery encouraged to reduce costs and environmental impact.
Voting matters and shareholder proposals
Proposals include: election of five directors, ratification of PricewaterhouseCoopers LLP as auditor for FY2026, and advisory approval of executive compensation.
Board recommends voting FOR all nominees and proposals.
Stockholders may submit director nominations and proposals for the 2027 annual meeting between September 30 and October 30, 2026.
Board of directors and corporate governance
Board is being declassified over a three-year phase-in, allowing for annual director elections.
Majority vote standard adopted for uncontested director elections; directors must tender resignation if receiving more withhold than for votes.
Board consists of eight members, with six independent directors; separate Chairman and CEO roles, and an independent Lead Director.
Board committees: Audit, Corporate Governance and Compensation, and Executive; all committee members are independent.
Board diversity emphasized; three of eight directors are women, and one is African American.
Latest events from BellRing Brands
- Strong 2025 sales and brand momentum, with 2026 guidance showing growth and margin pressure.BRBR
Q4 20259 Jul 2026 - Q2 net sales up 19% with Premier Protein driving record growth; FY2025 outlook reaffirmed.BRBR
Q2 20259 Jul 2026 - Premier Protein drove strong sales and EBITDA growth, with double-digit 2025 outlook despite margin pressures.BRBR
Q4 20248 Jul 2026 - Net sales up 1% to $537.3M, margins fell, 2026 outlook narrowed, CEO transition and settlements announced.BRBR
Q1 20268 Jul 2026 - Net sales and earnings surged, guidance raised, and Premier Protein drove record growth.BRBR
Q3 20248 Jul 2026 - Q2 sales rose 2% but margins and earnings fell sharply amid inflation and inventory charges.BRBR
Q2 20265 May 2026 - All proposals passed with strong support and no shareholder questions were raised.BRBR
AGM 20263 Feb 2026 - Q1 net sales up 24% and net earnings up 75%, with FY25 outlook raised on Premier Protein strength.BRBR
Q1 20258 Jan 2026 - Virtual annual meeting to vote on directors, auditor, and executive pay; online access promoted.BRBR
Proxy Filing16 Dec 2025